Near-Infrared Fluorescence Imaging Using a Protease-Specific Probe for the Detection of Colon Tumors
1
조회
0
다운로드
3
인용
0
참고문헌
초록
Background/Aims: Early tumor detection is crucial for the prevention of colon cancer. Near-infrared fluorescence (NIRF) imaging using a target-activatable probe may permit earlier disease detection. Matrix metalloproteinases (MMPs) participate in tumorigenesis and tumor growth. The aim of this study was to determine whether NIRF imaging using an MMP-activatable probe can detect colon tumors at early stages. Methods: We utilized two murine colon cancer models:a sporadic colon cancer model induced by azoxymethane (AOM), and a colitis-associated cancer model induced by a combination of AOM and dextran sodium sulfate (DSS). Colonic lesions were analyzed by histologic examination, Western blotting, immunohistochemical staining, and NIRF imaging using an MMP-activatable probe. Results: Multiple variable-sized tumors developed in both models and progressed from adenomas to adenocarcinomas over time. At the early stage of the AOM/DSS model, diffuse inflammation was observed within the tumors. MMP expression increased progressively through normal,inflammation, adenoma, and adenocarcionoma stages. NIRF signal intensities were strongly correlated with each tumor stage from adenoma to adenocarcinoma. NIRF imaging also distinguished tumors from inflamed mucosa. Conclusions: NIRF imaging using a protease-activatable probe may be a useful tool for early tumor detection. This approach could translate to improve the endoscopic detection of colon tumors, especially in patients with inflammatory bowel disease.
Abstract
Background/Aims: Early tumor detection is crucial for the prevention of colon cancer. Near-infrared fluorescence (NIRF) imaging using a target-activatable probe may permit earlier disease detection. Matrix metalloproteinases (MMPs) participate in tumorigenesis and tumor growth. The aim of this study was to determine whether NIRF imaging using an MMP-activatable probe can detect colon tumors at early stages. Methods: We utilized two murine colon cancer models:a sporadic colon cancer model induced by azoxymethane (AOM), and a colitis-associated cancer model induced by a combination of AOM and dextran sodium sulfate (DSS). Colonic lesions were analyzed by histologic examination, Western blotting, immunohistochemical staining, and NIRF imaging using an MMP-activatable probe. Results: Multiple variable-sized tumors developed in both models and progressed from adenomas to adenocarcinomas over time. At the early stage of the AOM/DSS model, diffuse inflammation was observed within the tumors. MMP expression increased progressively through normal,inflammation, adenoma, and adenocarcionoma stages. NIRF signal intensities were strongly correlated with each tumor stage from adenoma to adenocarcinoma. NIRF imaging also distinguished tumors from inflamed mucosa. Conclusions: NIRF imaging using a protease-activatable probe may be a useful tool for early tumor detection. This approach could translate to improve the endoscopic detection of colon tumors, especially in patients with inflammatory bowel disease.
참고문헌 (39)
- Jemal A, "Cancer statistics, 2008", CA Cancer J Clin, 58, pp.71~96 (2008)
- "Cancer incidence in five continents. Volume VIII", IARC Sci Publ, (155), pp.1~781 (2002)
- Sung JJ, "Increasing incidence of colorectal cancer in Asia: implications for screening", Lancet Oncol, 6, pp.871~876 (2005)
- Vogelstein B, "Genetic alterations during colorectal-tumor development", N Engl J Med, 319, pp.525~532 (1988)
- Winawer SJ, "Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup", N Engl J M, 329, pp.1977~1981 (1993)
- Fennerty MB, "Tissue staining (chromoscopy) of the gastrointestinal tract", Can J Gastroenterol, 13, pp.423~429 (1999)
- Nagata S, "Pit pattern diagnosis of early colorectal carcinoma by magnifying colonoscopy:clinical and histological implications", Int J Oncol, 16, pp.927~934 (2000)
- Gono K, "Appearance of enhanced tissue features in narrow-band endoscopic imaging", J Biomed Opt, 9, pp.568~577 (2004)
- Machida H, "Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study", Endoscopy, 36, pp.1094~1098 (2004)
- Rex DK, "Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies", Gastroenterology, 112, pp.24~28 (1997)
- Rembacken BJ, "Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK", Lancet, 355, pp.1211~1214 (2000)
- Eaden JA, "Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease", Gut, 51(Suppl 5), pp.V10~V12 (2002)
- Rutter M, "Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining", Endoscopy, 36, pp.1109~1114 (2004)
- Weissleder R, "Shedding light onto live molecular targets", Nat Med, 9, pp.123~128 (2003)
- Weissleder R, "Molecular imaging in cancer", Science, 312, pp.1168~1171 (2006)
- Marten K, "Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice", Gastroenterology, 122, pp.406~414 (2002)
- Alencar H, "Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice", Radiology, 244, pp.232~238 (2007)
- Zucker S, "A critical appraisal of the role of proteolytic enzymes in cancer invasion: emphasis on tumor surface proteinases", Cancer Invest, 6, pp.219~231 (1988)
- Koblinski JE, "Unraveling the role of proteases in cancer", Clin Chim Acta, 291, pp.113~135 (2000)
- Coussens LM, "Matrix metalloproteinase inhibitors and cancer: trials and tribulations", Science, 295, pp.2387~2392 (2002)
- Mysliwiec AG, "Matrix metalloproteinases in colorectal cancer", Clin Colorectal Cancer, 1, pp.208~219 (2002)
- Newell KJ, "Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis", Mol Carcinog, 10, pp.199~206 (1994)
- Gimeno-Garcia AZ, "Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence", Eur J Cancer, 42, pp.3246~3252 (2006)
- Herszenyi L, "Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon", Pathol Oncol Res, 14, pp.31~37 (2008)
- Lubbe WJ, "Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer", Clin Cancer Res, 12, pp.1876~1882 (2006)
- Zeng ZS, "Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9", J Clin Oncol, 14, pp.3133~3140 (1996)
- Boivin GP, "Pathology of mouse models of intestinal cancer: consensus report and recommendations", Gastroenterology, 124, pp.762~777 (2003)
- Nahrendorf M, "The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions", J Exp Med, 204, pp.3037~3047 (2007)
- Bloch S, "Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice", J Biomed Opt, 10, pp.054003~ (2005)
- Lee S, "Activatable imaging probes with amplified fluorescent signals", Chem Commun (Camb), (36), pp.4250~4260 (2008)
- Weissleder R, "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes", Nat Biotechnol, 17, pp.375~378 (1999)
- Bremer C, "In vivo molecular target assessment of matrix metalloproteinase inhibition", Nat Med, 7, pp.743~748 (2001)
- Moser AR, "A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse", Science, 247, pp.322~324 (1990)
- Becher OJ, "Genetically engineered models have advantages over xenografts for preclinical studies", Cancer Res, 66, pp.3355~3358 (2006)
- Nambiar PR, "Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic", knockout progenitors, 2003, pp.22, 145~150
- Tanaka T, "A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate", Cancer Sci, 94, pp.965~973 (2003)
- Suzuki R, "Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice", Carcinogenesis, 27, pp.162~169 (2006)
- Ekbom A, "Ulcerative colitis and colorectal cancer. A population-based study", N Engl J Med, 323, pp.1228~1233 (1990)
- Ekbom A, "Increased risk of large-bowel cancer in Crohn's disease with colonic involvement", Lancet, 336, pp.357~359 (1990)